# FDA 483 - Quincy Bioscience Holding Company, Inc. - March 16, 2023

Source: https://www.keypedia.com/records/483/quincy-bioscience-holding-company-inc/48cdc3a6-2d08-4f24-95ba-06a53f5c640c

> FDA 483 for Quincy Bioscience Holding Company, Inc. on March 16, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Quincy Bioscience Holding Company, Inc.
- Inspection Date: 2023-03-16
- Product Type: other
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Quincy Bioscience Holding Company, Inc., a dietary supplement own label distributor in Middleton, WI, revealed significant pest control deficiencies. The firm's physical plant exhibited widespread evidence of rodent activity, including numerous rodent excreta pellets and structural gaps allowing pest ingress. These conditions indicate a failure to maintain sanitary conditions within the facility.

## Related Officers

- [Peter T. Erlandson](https://www.keypedia.com/people/peter-t-erlandson/77f0f658-564f-415b-bf8f-12f27794570e)

Company: https://www.keypedia.com/companies/quincy-bioscience-holding-company-inc/fc08e999-9931-4c50-b00e-8a0065790c10

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d